Action King - KG

King Pharmaceuticals, Inc. (KG) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

14,24

( - )

Prix Achat

Prix Vente

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

14,24

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011

REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 PR Newswire CUPERTINO, Calif., Jan. 27, 2011 CUPERTINO...

Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura Pharmaceuticals

Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura Pharmaceuticals PR Newswire CHICAGO, Jan...

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY(R)

BRISTOL, Tenn. and SAN MATEO, Calif., Dec. 27, 2010 (GLOBE NEWSWIRE) -- King Pharmaceuticals®, Inc. (NYSE:KG) and Pain Therapeutics®, Inc...

REMOXY® New Drug Application Resubmitted

REMOXY® New Drug Application Resubmitted PR Newswire CUPERTINO, Calif., Dec. 27, 2010 CUPERTINO, Calif., Dec. 27, 2010 /PRNewswire-FirstCall/...

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY® PR Newswire BRISTOL, Tenn. and SAN MATEO...

King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets

King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets PR Newswire BRISTOL, Tenn. and...

Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.

Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc. PR Newswire NEW YORK, Dec. 15, 2010 NEW YORK, Dec. 15, 2010...

Standard & Poor's Announces Changes to U.S. Indices

Standard & Poor's Announces Changes to U.S. Indices PR Newswire NEW YORK, Dec. 9, 2010 NEW YORK, Dec. 9, 2010 /PRNewswire/ -- S&P will make the...

Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.

Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc. PR Newswire NEW YORK, Oct. 22 NEW YORK, Oct. 22...

The Law Office of Abe Shainberg is Launching an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Ki...

The Law Office of Abe Shainberg is investigating the Board of Directors of King Pharmaceuticals, Inc. (NYSE:KG) for possible...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

KG - Frequently Asked Questions (FAQ)

What is the current King Pharmaceuticals, Inc. share price?

The current share price of King Pharmaceuticals, Inc. is US$ 14,24

What is the 1 year trading range for King Pharmaceuticals, Inc. share price?

King Pharmaceuticals, Inc. has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

King Pharmaceuticals, Inc. (KG)

King Pharmaceuticals, Inc. (KG) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

KG Dernières nouvelles

REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011

Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura Pharmaceuticals

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY(R)

REMOXY® New Drug Application Resubmitted

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®

King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets

Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.

Standard & Poor's Announces Changes to U.S. Indices

Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.

The Law Office of Abe Shainberg is Launching an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Ki...

KG - Frequently Asked Questions (FAQ)

KG Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

King Pharmaceuticals, Inc. (KG)

King Pharmaceuticals, Inc. (KG) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

KG Dernières nouvelles

REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011

Zacks Analyst Blog Highlights: Pfizer, King Pharmaceuticals, Durect Pharma, Pain Therapeutics and Acura Pharmaceuticals

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY(R)

REMOXY® New Drug Application Resubmitted

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®

King Pharmaceuticals and Acura Pharmaceuticals Announce Submission of New Drug Application for ACUROX® Tablets

Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.

Standard & Poor's Announces Changes to U.S. Indices

Pfizer Commences Tender Offer for All Outstanding Shares of King Pharmaceuticals, Inc.

The Law Office of Abe Shainberg is Launching an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Ki...

KG - Frequently Asked Questions (FAQ)

KG Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Inscrivez-vous GRATUITEMENT et obtenez:

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE